Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-20-020510

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

HILZINGER KURT J · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-03-19 Grant or award : show line 1 in the form Stock Option (Right to Buy) +15,000 15,000 D
Loading xslF345X03/doc4.xml…